Spongistatin Synthetic Studies. An Efficient, Second-Generation Construction of an Advanced ABCD Intermediate (vol 4, pg 785, 2002)

被引：0
|
作者：
Smith, Amos B., III
Doughty, Victoria A.
Sfouggatakis, Chris
Bennett, Clay S.
Koyanagi, Jyunichi
Takeuchi, Makoto
机构：
来源：
ORGANIC LETTERS | 2009年 / 11卷 / 03期
关键词：
D O I：
10.1021/ol802831h
中图分类号：
O62 [有机化学];
学科分类号：
070303 ; 081704 ;
摘要：
引用
收藏
页码：785 / 785
页数：1
相关论文
共 7 条
  • [1] Spongistatin synthetic studies. An efficient, second-generation construction of an advanced ABCD intermediate
    Smith, AB
    Doughty, VA
    Sfouggatakis, C
    Bennett, CS
    Koyanagi, J
    Takeuchi, M
    [J]. ORGANIC LETTERS, 2002, 4 (05) : 783 - 786
  • [2] Spongistatin synthetic studies: An efficient second-generation construction of an advanced ABCD intermediate, fragment union, and final elaboration to (+)-spongistatin 1.
    Sfouggatakis, C
    Gotchev, D
    Zhu, WY
    Shirakami, S
    Doughty, V
    Bennett, C
    Smith, AB
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U82 - U82
  • [3] Total synthesis of (+)-spongistatin 1. An effective second-generation construction of an advanced EF Wittig salt, fragment union, and final elaboration
    Smith, AB
    Zhu, WY
    Shirakami, S
    Sfouggatakis, C
    Doughty, VA
    Bennett, CS
    Sakamoto, Y
    [J]. ORGANIC LETTERS, 2003, 5 (05) : 761 - 764
  • [4] Lituarine synthetic studies. An efficient, stereocontrolled construction of the common C(7-19) tricyclic spiroketal fragment. (vol 3, pg 3982, 2001)
    Smith, AB
    Frohn, M
    [J]. ORGANIC LETTERS, 2002, 4 (23) : 4183 - 4183
  • [5] Effects of the second-generation synthetic lipid A analogue E5564 on responses to endotoxin in equine whole blood and monocytes (vol 69, pg 796, 2008)
    Figueiredo, Monica D.
    Moore, James N.
    Vandenplas, Michel L.
    Sun, Wan-chun
    Murray, Thomas F.
    [J]. AMERICAN JOURNAL OF VETERINARY RESEARCH, 2008, 69 (08) : 1021 - 1021
  • [6] Review of bemiparin sodium - a new second-generation low molecular weight heparin and its applications in venous thromboembolism (vol 4, pg 1551, 2003)
    Planes, A
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (10) : 1888 - 1888
  • [7] Osimertinib in poor performance status patients with T790M-positive advanced non-small-cell lung cancer after progression of first- and second-generation EGFR-TKI treatments (NEJ032B) (vol 27, pg 112, 2022)
    Tsubata, Yukari
    Watanabe, Kana
    Saito, Ryota
    Nakamura, Atsushi
    Yoshioka, Hiroshige
    Morita, Mami
    Honda, Ryoichi
    Kanaji, Nobuhiro
    Oizumi, Satoshi
    Jingu, Daisuke
    Nakagawa, Taku
    Nakazawa, Kensuke
    Mouri, Atsuto
    Takeuchi, Susumu
    Furuya, Naoki
    Akazawa, Yuki
    Miura, Kiyotaka
    Ichihara, Eiki
    Maemondo, Makoto
    Morita, Satoshi
    Kobayashi, Kunihiko
    Isobe, Takeshi
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (04) : 823 - 824
1